BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:38 AM | Browse: 763 | Download: 2018
 |
Received |
|
2020-05-27 03:02 |
|
Peer-Review Started |
|
2020-05-25 02:03 |
|
First Decision by Editorial Office Director |
|
2020-09-14 00:46 |
|
Return for Revision |
|
2020-09-14 00:46 |
|
Revised |
|
2020-09-25 04:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-15 09:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-20 04:01 |
|
Articles in Press |
|
2020-10-20 04:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-03 06:43 |
|
Publish the Manuscript Online |
|
2020-11-06 09:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jina Yun, Sang W Lee, Sung H Lim, Se H Kim, Chan K Kim and Seong K Park |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Soonchunhyang University Research Fund |
20200011 |
|
| Corresponding Author |
Seong K Park, MD, Professor, Department of Internal Medicine, Division of Hematology-Oncology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, 170 Jomaru-ro, Bucheon 14584, South Korea. skpark@schmc.ac.kr |
| Key Words |
Antineoplastic combined chemotherapy protocols; Choriocarcinoma; Testicular neoplasms; Cyclophosphamide; Methotrexate; Case report |
| Core Tip |
Choriocarcinoma is an extremely rare germ cell tumor and responds poorly to standard chemotherapy. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine regimen is widely used to treat gestational trophoblastic tumors in females, however, its role in choriocarcinoma of males is seldom reported. This case report is the first of its kind demonstrating successful treatment using the etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine regimen in a male diagnosed with cisplatin-refractory high-risk non seminomatous germ cell tumors. |
| Publish Date |
2020-11-06 09:07 |
| Citation |
Yun J, Lee SW, Lim SH, Kim SH, Kim CK, Park SK. Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine: A case report. World J Clin Cases 2020; 8(21): 5334-5340 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i21/5334.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i21.5334 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
